{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:51:50Z","timestamp":1792792310435,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T00:00:00Z","timestamp":1457395200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.vaccine.2015.12.072","type":"journal-article","created":{"date-parts":[[2016,3,15]],"date-time":"2016-03-15T05:54:18Z","timestamp":1458021258000},"page":"2876-2879","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"title":["Status of vaccine research and development of vaccines for GBS"],"prefix":"10.1016","volume":"34","author":[{"given":"Paul T.","family":"Heath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2015.12.072_bib0195","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM200001063420103","article-title":"Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis","volume":"342","author":"Schrag","year":"2000","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2015.12.072_bib0200","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3201\/eid1302.060680","article-title":"Invasive group B streptococcal infection in infants: Malawi","volume":"13","author":"Gray","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2015.12.072_bib0205","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1179\/000349803125002814","article-title":"High burden of invasive Streptococcus agalactiae disease in South African infants","volume":"23","author":"Madhi","year":"2003","journal-title":"Ann Trop Paediatr"},{"issue":"1","key":"10.1016\/j.vaccine.2015.12.072_bib0210","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/cid\/cis395","article-title":"Variation in reported neonatal group B streptococcal disease incidence in developing countries","volume":"55","author":"Dagnew","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"9815","key":"10.1016\/j.vaccine.2015.12.072_bib0215","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(11)61651-6","article-title":"Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis","volume":"379","author":"Edmond","year":"2012","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2015.12.072_bib0220","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/jcp.2005.029058","article-title":"Carriage of group B streptococcus in pregnant women from Oxford: UK","volume":"59","author":"Jones","year":"2006","journal-title":"J Clin Pathol"},{"issue":"3","key":"10.1016\/j.vaccine.2015.12.072_bib0225","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJM200007203430303","article-title":"Rapid detection of group B streptococci in pregnant women at delivery","volume":"343","author":"Bergeron","year":"2000","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.vaccine.2015.12.072_bib0230","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/adc.2008.148874","article-title":"Group B streptococcal disease in infants: a case control study","volume":"94","author":"Heath","year":"2009","journal-title":"Arch Dis Child"},{"issue":"RR-7","key":"10.1016\/j.vaccine.2015.12.072_bib0235","first-page":"1","article-title":"Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention","volume":"45","year":"1996","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2015.12.072_bib0240","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1542\/peds.2011-3453","article-title":"Long-term outcomes of group B streptococcal meningitis","volume":"130","author":"Libster","year":"2012","journal-title":"Pediatrics"},{"issue":"7312","key":"10.1016\/j.vaccine.2015.12.072_bib0245","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/bmj.323.7312.533","article-title":"Meningitis in infancy in England and Wales: follow up at age 5 years","volume":"323","author":"Bedford","year":"2001","journal-title":"BMJ"},{"issue":"17","key":"10.1016\/j.vaccine.2015.12.072_bib0250","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.vaccine.2014.01.062","article-title":"Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa","volume":"32","author":"Kim","year":"2014","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2015.12.072_bib0255","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/1471-0528.13527","article-title":"Maternal group B Streptococcus-related stillbirth: a systematic review","volume":"122","author":"Nan","year":"2015","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.vaccine.2015.12.072_bib0260","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1084\/jem.67.1.25","article-title":"Two serological types of group B hemolytic streptococci with related: but not identical, type-specific substances","volume":"67","author":"Lancefield","year":"1938","journal-title":"J Exp Med"},{"issue":"November (18)","key":"10.1016\/j.vaccine.2015.12.072_bib0265","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1056\/NEJM198811033191802","article-title":"Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus","volume":"319","author":"Baker","year":"1988","journal-title":"New Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2015.12.072_bib0270","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1086\/375536","article-title":"Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III","volume":"188","author":"Baker","year":"2003","journal-title":"J Infect Dis"},{"issue":"July (24)","key":"10.1016\/j.vaccine.2015.12.072_bib0275","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1016\/S0264-410X(03)00353-0","article-title":"Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine","volume":"21","author":"Baker","year":"2003","journal-title":"Vaccine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2015.12.072_bib0280","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1086\/314574","article-title":"Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib","volume":"179","author":"Baker","year":"1999","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2015.12.072_bib0285","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1086\/382193","article-title":"Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines","volume":"189","author":"Baker","year":"2004","journal-title":"J Infect Dis"},{"issue":"87","key":"10.1016\/j.vaccine.2015.12.072_bib0290","first-page":"461","article-title":"Vaccines against influenza WHO position paper \u2013 November 2012","volume":"47","author":"WHO","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"issue":"9953","key":"10.1016\/j.vaccine.2015.12.072_bib0295","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(14)60686-3","article-title":"Effectiveness of maternal pertussis vaccination in England: an observational study","volume":"384","author":"Amirthalingam","year":"2014","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2015.12.072_bib0300","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa020205","article-title":"A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates","volume":"347","author":"Schrag","year":"2002","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2015.12.072_bib0305","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1046\/j.1440-1754.2001.00738.x","article-title":"Introduction of a conjugate meningococcal type C vaccine programme in the UK","volume":"37","author":"Salisbury","year":"2001","journal-title":"J Paediatr Child Health"},{"issue":"8","key":"10.1016\/j.vaccine.2015.12.072_bib0310","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.vaccine.2014.12.068","article-title":"Regulatory considerations in the clinical development of vaccines indicated for use during pregnancy","volume":"33","author":"Roberts","year":"2015","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2015.12.072_bib0315","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJM197604012941404","article-title":"Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection","volume":"294","author":"Baker","year":"1976","journal-title":"N Engl J Med"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2015.12.072_bib0320","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1586\/14760584.2014.953939","article-title":"Review on the association of Group B Streptococcus capsular antibody and protection against invasive disease in infants","volume":"14","author":"Dangor","year":"2015","journal-title":"Expert Rev Vaccines"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2015.12.072_bib0325","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/infdis\/jit549","article-title":"Maternal antibody at delivery protects neonates from early onset group B streptococcal disease","volume":"209","author":"Baker","year":"2014","journal-title":"J Infect Dis"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2015.12.072_bib0330","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1086\/422756","article-title":"Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen","volume":"190","author":"Lin","year":"2004","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2015.12.072_bib0335","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1128\/IAI.67.8.4303-4305.1999","article-title":"Measurement of human antibodies to type III group B Streptococcus","volume":"67","author":"Kasper","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.12.072_bib0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2015.01.030","article-title":"Natural acquired humoral immunity against serotype-specific group B Streptococcus rectovaginal colonization acquisition in pregnant women","author":"Kwatra","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2015.12.072_bib0345","doi-asserted-by":"crossref","first-page":"D52","DOI":"10.1016\/j.vaccine.2013.02.029","article-title":"Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants","volume":"31","author":"Madhi","year":"2013","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2015.12.072_bib0350","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1586\/erv.11.61","article-title":"An update on vaccination against group B streptococcus","volume":"10","author":"Heath","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"11","key":"10.1016\/j.vaccine.2015.12.072_bib0355","doi-asserted-by":"crossref","first-page":"6696","DOI":"10.1128\/IAI.69.11.6696-6701.2001","article-title":"Effects of alum adjuvant or a booster dose on immunogenicity during clinical trials of group B streptococcal type III conjugate vaccines","volume":"69","author":"Paoletti","year":"2001","journal-title":"Infect Immun"},{"issue":"28","key":"10.1016\/j.vaccine.2015.12.072_bib0360","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1016\/j.vaccine.2012.04.048","article-title":"Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines","volume":"30","author":"Edwards","year":"2012","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2015.12.072_bib0365","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0264-410X(98)00218-7","article-title":"Protection against experimental infection with group B streptococcus by immunization with a bivalent protein vaccine","volume":"17","author":"Larsson","year":"1999","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2015.12.072_bib0370","doi-asserted-by":"crossref","first-page":"F403","DOI":"10.1136\/adc.2005.090472","article-title":"Association between low concentrations of antibodies to protein alpha and Rib and invasive neonatal group B streptococcal infection","volume":"91","author":"Larsson","year":"2006","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"10.1016\/j.vaccine.2015.12.072_bib0375","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1086\/595564","article-title":"Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm","volume":"199","author":"Margarit","year":"2009","journal-title":"J Infect Dis"},{"issue":"37","key":"10.1016\/j.vaccine.2015.12.072_bib0380","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1016\/j.vaccine.2014.06.003","article-title":"Prevention of group B streptococcal disease in the first 3 months of life: would routine maternal immunization during pregnancy be cost-effective?","volume":"32","author":"Oster","year":"2014","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16002905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16002905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T04:06:35Z","timestamp":1655265995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16002905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":38,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0264410X16002905"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.12.072","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Status of vaccine research and development of vaccines for GBS","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.12.072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 World Health Organization; licensee Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}